Frequency: Weekly (Goes into printing every Tuesday; On stands …
Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle …
Several micro & small pharma units staring at closure as time for ...
2 days ago · With the deadline for the pharma units under Rs. 250 crore turnover to comply with the revised Schedule M manufacturing standards closed by the end of December, 2024, the …
Capricor Therapeutics seeks US FDA approval for deramiocel for …
18 hours ago · Capricor Therapeutics, a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, announced the …
2024 a landmark year for Indian pharma with advancements in ...
3 days ago · The year 2024 proved to be a landmark year for India's pharmaceutical sector, marked by notable advancements in drug manufacturing, healthcare technology, and …
News - Pharmabiz.com
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
AstraZeneca’s Imfinzi receives US FDA approval to treat patients …
Dec 6, 2024 · AstraZeneca’s Imfinzi (durvalumab) has been approved in the US for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has not …
India's most comprehensive portal on pharmaceutical News, …
Pharmabiz.com - India's most comprehensive online pharma news service. It provides updates on Indian pharma industry, allied sectors like hospitals & diagnostic services,pharma tenders, …
Annovis Bio gets US FDA clearance to begin pivotal phase 3 …
Oct 17, 2024 · Annovis Bio gets US FDA clearance to begin pivotal phase 3 studies of buntanetap, paving the way for NDAs filing: Malvern, Pennsylvania Thursday, October 17, …
US FDA clears Tyra Biosciences’ IND application to proceed with …
Oct 29, 2024 · US FDA clears Tyra Biosciences’ IND application to proceed with phase 2 study of TYRA-300 in paediatric achondroplasia: Carlsbad, California Tuesday, October 29, 2024, …
Pharma industry views US FDA guidance on developing drugs for …
Mar 26, 2024 · Pharma industry views US FDA guidance on developing drugs for early Alzheimer’s disease as invaluable: Nandita Vijayasimha, Bengaluru Tuesday, March 26, 2024, …